<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-KC2TV407</identifier><date>2025</date><creator>Morgan, Tina</creator><relation>documents/doc/K/URN_NBN_SI_doc-KC2TV407_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KC2TV407_001.txt</relation><format format_type="issue">2</format><format format_type="volume">76</format><format format_type="type">article</format><format format_type="extent">str. 123-129</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">236359683</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KC2TV407</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Astma</subject><subject language_type_id="eng">COPD</subject><subject language_type_id="eng">inhaled medication use</subject><subject language_type_id="slv">KOPB</subject><subject language_type_id="eng">medication adherence</subject><subject language_type_id="slv">Obstruktivne pljučne bolezni</subject><subject language_type_id="slv">sodelovanje pri zdravljenju z zdravili</subject><subject language_type_id="slv">uporaba vdihovalnikov</subject><title>Kako izboljšati zdravljenje astme in kronične obstruktivne pljučne bolezni</title><title>How to improve the pharmacologic management od asthma and chronic obstructive pulmonary disease</title></Record>